Display options
Cite
Principe L, Piazza A, Mauri C, et al. Multicenter prospective study on the prevalence of colistin resistance in . Infect Drug Resist. 2018;11:377-385doi: 10.2147/IDR.S160489.
Principe, L., Piazza, A., Mauri, C., Anesi, A., Bracco, S., Brigante, G., Casari, E., Agrappi, C., Caltagirone, M., Novazzi, F., Migliavacca, R., Pagani, L., & Luzzaro, F. (2018). Multicenter prospective study on the prevalence of colistin resistance in . Infection and drug resistance, 11377-385. https://doi.org/10.2147/IDR.S160489
Principe, Luigi, et al. "Multicenter prospective study on the prevalence of colistin resistance in ." Infection and drug resistance vol. 11 (2018): 377-385. doi: https://doi.org/10.2147/IDR.S160489
Principe L, Piazza A, Mauri C, Anesi A, Bracco S, Brigante G, Casari E, Agrappi C, Caltagirone M, Novazzi F, Migliavacca R, Pagani L, Luzzaro F. Multicenter prospective study on the prevalence of colistin resistance in . Infect Drug Resist. 2018 Mar 09;11:377-385. doi: 10.2147/IDR.S160489. eCollection 2018. PMID: 29563818; PMCID: PMC5849922.
Copy Download .nbib Format: NLM
Share it on

Infect Drug Resist. 2018 Mar 09;11:377-385. doi: 10.2147/IDR.S160489. eCollection 2018.

Multicenter prospective study on the prevalence of colistin resistance in .

Infection and drug resistance

Luigi Principe, Aurora Piazza, Carola Mauri, Adriano Anesi, Silvia Bracco, Gioconda Brigante, Erminia Casari, Carlo Agrappi, Mariasofia Caltagirone, Federica Novazzi, Roberta Migliavacca, Laura Pagani, Francesco Luzzaro

Affiliations

  1. Microbiology and Virology Unit, A. Manzoni Hospital, Lecco, Italy.
  2. Clinical-Surgical, Diagnostic and Pediatric Sciences Department, Unit of Microbiology and Clinical Microbiology, University of Pavia, Pavia, Italy.
  3. Romeo and Enrica Invernizzi Pediatric Research Center, Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
  4. Clinical Pathology Laboratory, ASST Lodi, Lodi, Italy.
  5. Clinical Pathology Laboratory, ASST Vimercate, Vimercate, Italy.
  6. Clinical Pathology Laboratory, ASST Valle Olona, Busto Arsizio, Italy.
  7. Clinical Pathology Laboratory, IRCCS "Humanitas," Rozzano, Italy.
  8. Microbiology and Virology Unit, ASST Ovest Milanese, Legnano, Italy.

PMID: 29563818 PMCID: PMC5849922 DOI: 10.2147/IDR.S160489

Abstract

BACKGROUND: The emergence of the plasmid-mediated colistin resistance mechanism in

MATERIALS AND METHODS: A prospective study was performed during a 4-month period (May to August, 2016) in six acute care Hospitals. Consecutive nonduplicate clinical isolates of

RESULTS: Overall, 3,902 consecutive

CONCLUSION: Resistance to colistin in

Keywords: Escherichia coli; MCR-1; colistin; epidemiology; prevalence; surveillance

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. Appl Environ Microbiol. 2000 Oct;66(10):4555-8 - PubMed
  2. J Microbiol Methods. 2005 Dec;63(3):219-28 - PubMed
  3. Mol Microbiol. 2006 Jun;60(5):1136-51 - PubMed
  4. Antimicrob Agents Chemother. 2011 Jan;55(1):388-9 - PubMed
  5. J Antimicrob Chemother. 2012 Mar;67(3):638-51 - PubMed
  6. Plasmid. 2012 Jul;68(1):43-50 - PubMed
  7. J Antimicrob Chemother. 2015 Jan;70(1):75-80 - PubMed
  8. Euro Surveill. 2014 Oct 23;19(42):null - PubMed
  9. J Clin Microbiol. 2015 Oct;53(10):3341-4 - PubMed
  10. Int J Antimicrob Agents. 2015 Sep;46(3):297-306 - PubMed
  11. Clin Microbiol Infect. 2015 Dec;21(12):1106.e1-8 - PubMed
  12. J Antimicrob Chemother. 2015 Dec;70(12):3402-4 - PubMed
  13. Clin Infect Dis. 2015 Nov 15;61(10):1628-9 - PubMed
  14. Lancet Infect Dis. 2016 Feb;16(2):161-8 - PubMed
  15. Int J Antimicrob Agents. 2016 Jan;47(1):1-3 - PubMed
  16. Lancet Infect Dis. 2016 Mar;16(3):281-2 - PubMed
  17. Lancet Infect Dis. 2016 Mar;16(3):283-4 - PubMed
  18. Lancet Infect Dis. 2016 Mar;16(3):293 - PubMed
  19. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3257-8 - PubMed
  20. Clin Microbiol Infect. 2016 May;22(5):398-400 - PubMed
  21. Euro Surveill. 2016;21(13):null - PubMed
  22. J Antimicrob Chemother. 2016 Aug;71(8):2327-9 - PubMed
  23. Antimicrob Agents Chemother. 2016 Jun 20;60(7):4412-3 - PubMed
  24. Int J Antimicrob Agents. 2016 Aug;48(2):119-26 - PubMed
  25. J Antimicrob Chemother. 2016 Aug;71(8):2329-31 - PubMed
  26. J Antimicrob Chemother. 2016 Aug;71(8):2066-70 - PubMed
  27. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5612-5 - PubMed
  28. Euro Surveill. 2016 Jul 7;21(27): - PubMed
  29. Int J Infect Dis. 2016 Oct;51:4-5 - PubMed
  30. Antimicrob Agents Chemother. 2016 Nov 21;60(12):7532-7534 - PubMed
  31. Enferm Infecc Microbiol Clin. 2017 Aug - Sep;35(7):467-468 - PubMed
  32. Int J Antimicrob Agents. 2016 Dec;48(6):598-606 - PubMed
  33. Int J Infect Dis. 2017 Jan;54:77-84 - PubMed
  34. Lancet Infect Dis. 2017 Apr;17(4):400-410 - PubMed
  35. Lancet Infect Dis. 2017 Apr;17(4):390-399 - PubMed
  36. Int J Antimicrob Agents. 2017 Apr;49(4):493-497 - PubMed
  37. Clin Microbiol Rev. 2017 Apr;30(2):557-596 - PubMed
  38. J Antimicrob Chemother. 2017 Jul 1;72(7):2127-2129 - PubMed
  39. Euro Surveill. 2017 Apr 20;22(16):null - PubMed
  40. Antimicrob Agents Chemother. 2017 Jul 25;61(8): - PubMed
  41. PLoS One. 2017 Jun 2;12(6):e0178598 - PubMed
  42. MBio. 2017 Jun 27;8(3): - PubMed
  43. J Glob Antimicrob Resist. 2017 Sep;10:80-83 - PubMed
  44. Sci Rep. 2017 Jul 11;7(1):5071 - PubMed
  45. Chemotherapy. 2017;62(6):339-342 - PubMed
  46. Euro Surveill. 2017 Aug 3;22(31):null - PubMed
  47. Euro Surveill. 2017 Aug 3;22(31):null - PubMed
  48. Euro Surveill. 2017 Aug 3;22(31):null - PubMed
  49. Euro Surveill. 2017 Aug 3;22(31):null - PubMed
  50. Euro Surveill. 2017 Aug 3;22(31):null - PubMed
  51. Antimicrob Agents Chemother. 2017 Oct 24;61(11): - PubMed
  52. J Antimicrob Chemother. 2017 Dec 1;72(12):3317-3324 - PubMed
  53. Clin Infect Dis. 2018 Feb 10;66(5):676-685 - PubMed
  54. Int J Antimicrob Agents. 2018 Jan;51(1):163-164 - PubMed

Publication Types